WST Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$445.33median target· current $412.62 (+7.9%)17 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
46 articles · sorted by datePage 1 of 3 · 46 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio52.83Forward 42.37
EPS (TTM)$7.8157.3% YoY
Profit margin18.8%HEALTHCARE
Market cap$28.79BLarge cap
Valuation
- Forward P/E
- 42.37
- PEG ratio
- 3.21
- P/B
- 9.68
- P/S (TTM)
- 8.48
- EV/EBITDA
- 29.11
Profitability & growth
- ROE (TTM)
- 21.2%
- Operating margin
- 30.6%
- Revenue growth YoY
- 8.7%
- Dividend yield
- 0.2%
- Beta
- 1.13
Last earnings
Oct 29, 2026 · Estimate $2.18 · Reported $2.66
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About West Pharmaceutical Services Inc
Company profileWest Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.
Classification
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 530 HERMAN O. WEST DRIVE, EXTON, PA
- Fiscal year end
- December
- Latest quarter
- Sep 30, 2026
Market cap$28.79B
Shares outstanding$69.8M
52W high$438.27
52W low$223.52
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent